Ivermectin's reputation keeps growing as a kind of cure-all, even for cancer — despite evidence it doesn't work.

"I don't want to overpromise" because "anecdotal reports" may not include failures, Dr. Harvey Risch exclusively tells Just the News/Real America's Voice special report. He challenges pharma to work ...

The post Senator Endorses Discredited Doctor’s Book on a Chemical He Claims Treats Everything From Autism to Cancer appeared first on ProPublica.

High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say ...

TOGETHER Trial, a research consortium that studies the use of existing drugs as treatments for diseases, produced one of the most significant studies labeling ivermectin ineffective at reducing ...

A recent study published in the Journal of American Medical Association (JAMA) evaluated the effect of ivermectin on time to recovery from coronavirus disease 2019 (COVID-19) in patients with mild to ...

A long-awaited study at the University of Minnesota has found that the controversial drug ivermectin is not effective at treating COVID-19. The findings, published Wednesday in the New England Journal ...

Researchers at Duke University and Vanderbilt University concluded in a pre-print study that the drug ivermectin, approved for treating parasitic illnesses in livestock, did very little to resolve ...

Ivermectin does not reduce the length of COVID-19 symptoms or hospitalizations, a large clinical trial headed by Duke researchers suggests. The research was posted online Sunday, but has not yet been ...

The controversial drug ivermectin failed in a large U.S. trial to reduce COVID-19 hospitalizations and deaths, but a University of Minnesota co-investigator said it warrants continued study because it ...

A new clinical trial is the largest to date testing the antiparasitic drug on people with Covid. By Carl Zimmer The antiparasite drug ivermectin does not meaningfully reduce the time needed to recover ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a thing of the past, today announced it has dosed the first participant ...